VANCOUVER, June 22 /PRNewswire-FirstCall/ -- Dragon Pharmaceutical Inc. ("Dragon Pharma" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company, today...
VANCOUVER, May 19 /PRNewswire-FirstCall/ -- Dragon Pharmaceutical Inc. ("Dragon Pharma" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company, today...
VANCOUVER, Sept. 25 /PRNewswire-FirstCall/ -- Dragon Pharmaceutical Inc. ("Dragon Pharma" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company...
VANCOUVER, June 26 /PRNewswire-FirstCall/ -- Dragon Pharmaceutical Inc. ("Dragon Pharma" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company, today...
VANCOUVER, May 24 /PRNewswire-FirstCall/ -- Dragon Pharmaceutical Inc. ("Dragon Pharma" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company, today...
VANCOUVER, March 31 /PRNewswire-FirstCall/ -- Dragon Pharmaceutical Inc. ("Dragon" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company, today...
VANCOUVER, March 17 /PRNewswire-FirstCall/ -- Dragon Pharmaceutical Inc. ("Dragon" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company, today...
VANCOUVER, March 5 /PRNewswire-FirstCall/ -- Dragon Pharmaceutical Inc. ("Dragon" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company today...
VANCOUVER, Nov. 14 /PRNewswire-FirstCall/ -- Dragon Pharmaceutical Inc. (TSX: DDD; OTCBB: DRUG; BBSE: DRP) today announced that it has entered an agreement with an unaffiliated party for the...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 7.06 | 11.8695359785 | 59.48 | 67.46 | 52.92 | 2035 | 58.17383156 | CS |
4 | -5.87 | -8.10661510841 | 72.41 | 79.98 | 42.35 | 7795 | 62.36560483 | CS |
12 | 65.07 | 4426.53061224 | 1.47 | 108 | 1.35 | 16141 | 52.66261006 | CS |
26 | 64.95 | 4084.90566038 | 1.59 | 108 | 1.3 | 7902 | 50.04694512 | CS |
52 | 64.73 | 3576.24309392 | 1.81 | 108 | 1.29 | 4381 | 45.82157561 | CS |
156 | 41.24 | 163.003952569 | 25.3 | 108 | 1.29 | 11105 | 15.15600763 | CS |
260 | 36.54 | 121.8 | 30 | 108 | 1.29 | 11395 | 20.0163465 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約